Oruka Therapeutics (ORKA) Other financing activities (2010 - 2024)
Oruka Therapeutics (ORKA) recorded quarterly Other financing activities of -$174000.0 in Q4 2024, down 100.08% quarter-over-quarter from $226.5 million in Q3 2024.
Oruka Therapeutics (ORKA) Other financing activities (2010 - 2024) Analysis & Trends
Oruka Therapeutics' Other financing activities history runs 12 years deep, the most recent figure standing at -$174000.0 for Q4 2024.
- In Q4 2024, Other financing activities changed N/A year-over-year to -$174000.0; the TTM figure through Dec 2024 stood at $228.0 million (changed N/A YoY), while the FY2024 annual figure was $228.0 million, changed N/A from the prior year.
- Other financing activities was -$174000.0 for Q4 2024 at Oruka Therapeutics, down from $226.5 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $226.5 million in Q3 2024 to a low of -$174000.0 in Q4 2024.
- Historically, Other financing activities has averaged $32.9 million across 3 years, with a median of $977000.0 in 2021.
- Biggest YoY gain for Other financing activities was 3125.0% in 2020; the steepest drop was 1617.28% in 2020.
- A 3-year view of Other financing activities shows it stood at $129000.0 in 2020, then jumped by 657.36% to $977000.0 in 2021, then tumbled by 117.81% to -$174000.0 in 2024.
- The last three Other financing activities figures came in at -$174000.0 (Q4 2024), $226.5 million (Q3 2024), and $1.5 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Oruka Therapeutics | 4.04 Bn | 3.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -174,000.00 |
| Dec 31, 2024 | -174,000.00 |
| Sep 30, 2024 | 226.54 Mn |
| Sep 30, 2024 | 226.54 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2021 | 977,000.00 |
| Mar 31, 2021 | 977,000.00 |
| Dec 31, 2020 | 129,000.00 |
| Dec 31, 2020 | 129,000.00 |
| Sep 30, 2020 | 1.39 Mn |
| Sep 30, 2020 | 1.39 Mn |
| Dec 31, 2019 | 4,000.00 |
| Dec 31, 2019 | 4,000.00 |
| Sep 30, 2019 | 81,000.00 |
| Sep 30, 2019 | 81,000.00 |
| Jun 30, 2019 | 170,000.00 |
| Jun 30, 2019 | 170,000.00 |